Results 151 to 160 of about 14,887 (173)

Ezetimibe, and the combination of ezetimibe/simvastatin, and risk of cancer: A post-marketing analysis

Journal of Clinical Lipidology, 2009
Richard Karas, Alawi Alsheikh-Ali
exaly  

Variability of the LDL-C lowering response to ezetimibe and ezetimibe + statin therapy in hypercholesterolemic patients

Atherosclerosis, 2015
Olivier Descamps, Joanne E Tomassini, Arvind Shāh   +2 more
exaly  

First synthesis and characterization of SRR/RSS-Ezetimibe

Tetrahedron Letters, 2013
Yong Deng, Li Hai, Mei Guan
exaly  

Ezetimibe

2017
openaire   +2 more sources

Ezetimibe-related myopathy: A systematic review

Journal of Clinical Lipidology, 2008
Paul D Thompson
exaly  

Physicochemical characterization of ezetimibe and its impurities

Journal of Molecular Structure, 2011
Katarzyna Sidoryk, Marta Łaszcz, Joanna Zagrodzka   +2 more
exaly  

Efficacy, safety and effect on biomarkers related to cholesterol and lipoprotein metabolism of rosuvastatin 10 or 20 mg plus ezetimibe 10 mg vs. simvastatin 40 or 80 mg plus ezetimibe 10 mg in high-risk patients: Results of the GRAVITY randomized study

Atherosclerosis, 2014
Christie Ballantyne, Ron Hoogeveen, Björn W Karlson   +2 more
exaly  

A LC–MS/MS method to quantify the novel cholesterol lowering drug ezetimibe in human serum, urine and feces in healthy subjects genotyped for SLCO1B1

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 2006
Stefan Oswald, Ingolf Cascorbi, Eberhard Scheuch   +2 more
exaly  

Effects of simvastatin, ezetimibe and simvastatin/ezetimibe on mitochondrial function and leukocyte/endothelial cell interactions in patients with hypercholesterolemia

Atherosclerosis, 2016
Celia Bañuls, Angeles Alvarez, VÍCTOR Vm   +2 more
exaly  

A multicenter, randomized, double-blind, placebo-controlled, factorial design study to evaluate the lipid-altering efficacy and safety profile of the ezetimibe/simvastatin tablet compared with ezetimibe and simvastatin monotherapy in patients with primary hypercholesterolemia

Clinical Therapeutics, 2004
Harold Bays, Leiv Osé, Amy O Johnson-Levonas   +2 more
exaly